BRIEF- IBA to divest PharmaLogic PET Services of Montreal company assets

BRUSSELS, March 17 Mon Mar 17, 2014 2:10am EDT

BRUSSELS, March 17 (Reuters) - Ion Beam Applications SA : * Says IBA closes agreement to divest PharmaLogic pet services of Montreal company assets * About 85 percent of price has been paid to PharmaLogic at closing and rest will be released after a two year period * Says payments will then be distributed as dividends to PharmaLogic's shareholders, including IBA * Says expects a net total cash inflow in dividend from this sale of about EUR 7.7 million * Deal will have no impact on 2013 accounts, but should positively impact IBA's 2014 net results by approximately EUR 3.5 million